HM
BSX icon

HealthCor Management’s Boston Scientific BSX Stock Holding History

HealthCor Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-958,600
Closed -$37.1M – 32
2022
Q3 		$37.1M Sell
958,600
-849,390
-47% -$34.1M 4.64% 4
2022
Q2 		$67.4M Sell
1,807,990
-42,460
-2% -$1.73M 6.77% 3
2022
Q1 		$82M Buy
1,850,450
+586,780
+46% +$25.4M 5.47% 2
2021
Q4 		$53.7M Sell
1,263,670
-444,011
-26% -$18.7M 2.92% 11
2021
Q3 		$74.1M Buy
1,707,681
+497,111
+41% +$22M 3.2% 10
2021
Q2 		$51.8M Buy
1,210,570
+35,750
+3% +$1.5M 2.07% 18
2021
Q1 		$45.4M Buy
+1,174,820
New +$44.5M 1.61% 23
2019
Q4 		– Sell
-961,820
Closed -$39.1M – 63
2019
Q3 		$39.1M Sell
961,820
-509,550
-35% -$21.6M 1.48% 31
2019
Q2 		$63.2M Buy
1,471,370
+174,410
+13% +$6.71M 2.45% 14
2019
Q1 		$49.8M Sell
1,296,960
-497,650
-28% -$19M 2.01% 20
2018
Q4 		$63.4M Buy
1,794,610
+391,660
+28% +$14.2M 1.98% 21
2018
Q3 		$54M Buy
1,402,950
+695,090
+98% +$24.3M 1.79% 25
2018
Q2 		$23.1M Buy
707,860
+134,380
+23% +$4.05M 0.74% 37
2018
Q1 		$15.7M Buy
573,480
+205,648
+56% +$5.59M 0.53% 43
2017
Q4 		$9.12M Sell
367,832
-319,338
-46% -$8.81M 0.3% 35
2017
Q3 		$20M Buy
687,170
+233,220
+51% +$6.44M 0.67% 35
2017
Q2 		$12.6M Buy
+453,950
New +$12M 0.45% 35
2015
Q2 		– Sell
-2,386,700
Closed -$42.4M – 59
2015
Q1 		$42.4M Sell
2,386,700
-1,074,500
-31% -$17M 2.02% 20
2014
Q4 		$45.9M Buy
+3,461,200
New +$44.2M 2.56% 16

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

HealthCor Management's BSX Position: Q4 2022 in Review

HealthCor Management sold out of Boston Scientific (BSX) in Q4 2022, closing a stake of 958,600 shares — an estimated $37.1M sold.

HealthCor Management first reported a position in BSX in Q4 2014 and held it in 19 quarters. The position peaked at $82M in Q1 2022. 929 funds tracked by Wall St. Rank hold BSX as of Q4 2022.

  • HealthCor Management reported no remaining Boston Scientific position as of Q4 2022 after selling out during the quarter.
  • HealthCor Management sold 958,600 Boston Scientific shares in Q4 2022, an estimated $37.1M.
  • HealthCor Management first reported a position in Boston Scientific in Q4 2014 and held it in 19 quarters.
  • HealthCor Management's Boston Scientific position peaked at $82M in Q1 2022.
  • 929 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2022.

Based on HealthCor Management's 13F filing for Q4 2022, filed 15 Feb 2023.